Skip Navigation

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

Brief Summary

Brain Tumors / Neurologic Cancers

Study Type:

III Identifier:

Study #:
CMH - ANBL1232

Start Date:
Mar 05, 2015

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT02176967

View Complete Trial Details & Eligibility at